The purpose of this study was to evaluate photodynamic properties of indocyanine green (ICG), brilliant blue G (BBG) and trypan blue (TB) as currently used vital dyes for chromovitrectomy. Under consideration of intraoperative illumination intensities and dye concentrations, a simulative in vitro investigation was set up. Therefore, standardized dilutions of original ICG, BBG and TB vials were irradiated at a wavelength of 366 nm with an intensity of 14 µW/cm2 between 0 and 48 h. After this, all samples were measured spectroscopically in a 220- to 750-nm bandwidth. Analyzing the vital dyes over the time course, an exponential photolysis was observed for ICG, whereas BBG and TB presented photostable properties. Regarding ICG, 5% of the concentration was degraded to toxic metabolites every 20 min. For this reason, our study provides evidence that intraocular dye concentrations and modern endoillumination systems alone cannot fully prevent ICG photodegradation.

Keywords:
Indocyanine green, Brilliant blue G, Trypan blue, Vital dye, Spectroscopy, Chromovitrectomy
1.
Farah ME, Maia M, Rodrigues EB: Dyes in ocular surgery: principles for use in chromovitrectomy. Am J Ophthalmol 2009;148:332–340.
2.
Mennel S, Meyer CH, Schmidt JC, Kaempf S, Thumann G: Trityl dyes patent blue v and brilliant blue G – clinical relevance and in vitro analysis of the function of the outer blood-retinal barrier. Dev Ophthalmol 2008;42:101–114.
3.
Kwok AK, Lai TY, Li WW, Yew DT, Wong VW: Trypan blue- and indocyanine green-assisted epiretinal membrane surgery: clinical and histopathological studies. Eye (Lond) 2004;18:882–888.
4.
Balaiya S, Brar VS, Murthy RK, Chalam KV: Comparative in vitro safety analysis of dyes for chromovitrectomy: indocyanine green, brilliant blue green, bromophenol blue, and infracyanine green. Retina 2011;31:1128–1136.
5.
Rodrigues EB, Meyer CH, Mennel S, Farah ME: Mechanisms of intravitreal toxicity of indocyanine green dye: implications for chromovitrectomy. Retina 2007;27:958–970.
6.
Stanescu-Segall D, Jackson TL: Vital staining with indocyanine green: a review of the clinical and experimental studies relating to safety. Eye (Lond) 2009;23:504–518.
7.
Rizzo S, Belting C, Genovesi-Ebert F, Vento A, Cresti F: Modified technique for safer indocyanine-green-assisted peeling of the internal limiting membrane during vitrectomy for macular hole repair. Graefes Arch Clin Exp Ophthalmol 2006;244:1615–1619.
8.
Jackson TL, Vote B, Knight BC, El-Amir A, Stanford MR, Marshall J: Safety testing of infracyanine green using retinal pigment epithelium and glial cell cultures. Invest Ophthalmol Vis Sci 2004;45:3697–3703.
9.
Haritoglou C, Gandorfer A, Gass CA, Kampik A: Histology of the vitreoretinal interface after staining of the internal limiting membrane using glucose 5% diluted indocyanine and infracyanine green. Am J Ophthalmol 2004;137:345–348.
10.
van den Biesen PR, Berenschot T, Verdaasdonk RM, van Weelden H, van Norren D: Endoillumination during vitrectomy and phototoxicity thresholds. Br J Ophthalmol 2000;84:1372–1375.
11.
Ach T, Höh AE, Amberger R, Dithmar S: Exposure to light during vitreoretinal surgery. II. Characteristics of endoilluminators (in German). Ophthalmologe 2008;105:905–910.
12.
Hillenkamp J, Dydykina S, Klettner A, Treumer F, Vasold R, Bäumler W, Roider J: Safety testing of indocyanine green with different surgical light sources and the protective effect of optical filters. Retina 2010;30:1685–1691.
13.
Ohguro H, Ohguro I, Ishikawa F, Hitoshi Y, Yokoi Y, Nakazawa M: Changes in intraocular indocyanine green concentrations during macular hole surgery. Ophthalmologica 2007;221:402–405.
14.
Morales MC, Freire V, Asumendi A, Araiz J, Herrera I, Castiella G, Corcóstegui I, Corcóstegui G: Comparative effects of six intraocular vital dyes on retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 2010;51:6018–6029.
15.
Engel E, Schraml R, Maisch T, Kobuch K, König B, Szeimies RM, Hillenkamp J, Bäumler W, Vasold R: Light-induced decomposition of indocyanine green. Invest Ophthalmol Vis Sci 2008;49:1777–1783.
16.
Brockmann T, Steger C, Westermann M, Nietzsche S, Koenigsdoerffer E, Strobel J, Dawczynski J: Ultrastructure of the membrana limitans interna after dye-assisted membrane peeling. Ophthalmologica 2011;226:228–233.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.